Global Blood Therapeutics, Inc. News Releases https://ir.gbt.com/ Global Blood Therapeutics, Inc. News Releases en GBT Announces Upcoming Data Presentations at 24th European Hematology Association (EHA) Congress Supporting Voxelotor Sickle Cell Disease Program https://ir.gbt.com/news-releases/news-release-details/gbt-announces-upcoming-data-presentations-24th-european Phase 3 HOPE Study 24-Week Efficacy Results from Full Patient Cohort  to be Presented During Presidential Symposium New Drug Application (NDA) Submission Planned for Voxelotor to Include HOPE Study Data Being Presented at EHA 2019 Company to Host Investor Webcast on Friday, June 14 SOUTH SAN Thu, 16 May 2019 09:05:00 -0400 Global Blood Therapeutics, Inc. News Releases 9576 GBT Reports Recent Business Progress and First Quarter 2019 Financial Results https://ir.gbt.com/news-releases/news-release-details/gbt-reports-recent-business-progress-and-first-quarter-2019 SOUTH SAN FRANCISCO, Calif. , May 08, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics , Inc. (GBT) (NASDAQ: GBT) today reported recent business progress and financial results for the first quarter ended March 31, 2019. “With a goal of getting voxelotor to the sickle cell community as quickly as Wed, 08 May 2019 16:05:00 -0400 Global Blood Therapeutics, Inc. News Releases 9551 GBT Announces New Employment Inducement Grants https://ir.gbt.com/news-releases/news-release-details/gbt-announces-new-employment-inducement-grants-19 SOUTH SAN FRANCISCO, Calif. , May 06, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics , Inc. (GBT) (NASDAQ: GBT) today announced that on May 1, 2019 , the compensation committee of GBT’s board of directors granted nine new employees options to purchase an aggregate of 24,600 shares of the Mon, 06 May 2019 08:00:00 -0400 Global Blood Therapeutics, Inc. News Releases 9546 GBT Announces New Employment Inducement Grants https://ir.gbt.com/news-releases/news-release-details/gbt-announces-new-employment-inducement-grants-18 SOUTH SAN FRANCISCO, Calif. , April 03, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics , Inc. (GBT) (NASDAQ: GBT) today announced that on April 1, 2019 , the compensation committee of GBT’s board of directors granted 10 new employees restricted stock units representing an aggregate of 30,500 Wed, 03 Apr 2019 08:00:45 -0400 Global Blood Therapeutics, Inc. News Releases 9476 GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference https://ir.gbt.com/news-releases/news-release-details/gbt-announces-participation-hc-wainwright-global-life-sciences-1 SOUTH SAN FRANCISCO, Calif. , April 02, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the H.C. Wainwright Global Life Sciences Conference in London on Tuesday, April 9, 2019 , at 10:10 a.m. British Summer Time. Tue, 02 Apr 2019 08:01:17 -0400 Global Blood Therapeutics, Inc. News Releases 9471 GBT Announces New Employment Inducement Grants https://ir.gbt.com/news-releases/news-release-details/gbt-announces-new-employment-inducement-grants-17 SOUTH SAN FRANCISCO, Calif. , March 06, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics , Inc. (GBT) (NASDAQ: GBT) today announced that on March 1, 2019 , the compensation committee of GBT’s board of directors granted 10 new employees options to purchase an aggregate of 76,100 shares of the Wed, 06 Mar 2019 08:01:12 -0500 Global Blood Therapeutics, Inc. News Releases 9256 GBT Announces Participation at the Cowen and Company 39th Annual Health Care Conference https://ir.gbt.com/news-releases/news-release-details/gbt-announces-participation-cowen-and-company-39th-annual-health SOUTH SAN FRANCISCO, Calif. , March 04, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the Cowen and Company 39 th Annual Health Care Conference in Boston on Monday, March 11, 2019 , at 4:50 p.m. Eastern Time . Mon, 04 Mar 2019 08:00:59 -0500 Global Blood Therapeutics, Inc. News Releases 9251 GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2018 Financial Results https://ir.gbt.com/news-releases/news-release-details/gbt-reports-recent-business-progress-and-fourth-quarter-and-1 Pre-NDA Meeting Completed and Company Announces FDA Agreed to a Rolling Submission of New Drug Application for Voxelotor for the Potential Treatment of Sickle Cell Disease SOUTH SAN FRANCISCO, Calif. , Feb. 27, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics , Inc. (GBT) (NASDAQ: GBT) today Wed, 27 Feb 2019 16:05:39 -0500 Global Blood Therapeutics, Inc. News Releases 9246 GBT Announces Participation at the 8th Annual SVB Leerink Global Healthcare Conference https://ir.gbt.com/news-releases/news-release-details/gbt-announces-participation-8th-annual-svb-leerink-global SOUTH SAN FRANCISCO, Calif. , Feb. 21, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York on Thursday, February 28, 2019 , at 1 p.m. Eastern Time . Thu, 21 Feb 2019 08:01:08 -0500 Global Blood Therapeutics, Inc. News Releases 9241 GBT Launches ACCEL Grants Program to Improve Access to Care for People with Sickle Cell Disease https://ir.gbt.com/news-releases/news-release-details/gbt-launches-accel-grants-program-improve-access-care-people —The Access to Excellent Care for Sickle Cell Patients Pilot Program ( ACCEL ) Supports Novel Projects Aimed at Improving Access to High-Quality Healthcare for People with Sickle Cell Disease— —GBT Will Fund Proposals With the Highest Potential to Impact Patient Care— SOUTH SAN FRANCISCO, Calif. Tue, 19 Feb 2019 08:00:35 -0500 Global Blood Therapeutics, Inc. News Releases 9236